CCL15



CCL15

Q1QQ1F2FF2I3II3N4NN4D5DD5A6AA6E7EE7T8TT8E9EE9L10LL10M11MM11M12MM12S13SS13K14KK14L15LL15P16PP16L17LL17E18EE18N19NN19P20PP20V21VV21V22VV22L23LL23N24NN24S25SS25F26FF26H27HH27F28FF28A29AA29A30AA30D31DD31C32CC32C33CC33T34TT34S35SS35Y36YY36I37II37S38SS38Q39QQ39S40SS40I41II41P42PP42C43CC43S44SS44L45LL45M46MM46K47KK47... and 45 more residue(s)...... and 45 more residue(s)

SMILES None
InChIKey None
Sequence QFINDAETELMMSKLPLENPVVLNSFHFAADCCTSYISQSIPCSLMKSYFETSSECSKPGVIFLTKKGRQVCAKPSGPGVQDCMKKLKPYSI

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL15

Q1QQ1F2FF2I3II3N4NN4D5DD5A6AA6E7EE7T8TT8E9EE9L10LL10M11MM11M12MM12S13SS13K14KK14L15LL15P16PP16L17LL17E18EE18N19NN19P20PP20V21VV21V22VV22L23LL23N24NN24S25SS25F26FF26H27HH27F28FF28A29AA29A30AA30D31DD31C32CC32C33CC33T34TT34S35SS35Y36YY36I37II37S38SS38Q39QQ39S40SS40I41II41P42PP42C43CC43S44SS44L45LL45M46MM46K47KK47... and 45 more residue(s)...... and 45 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.